Drug maker Eli Lilly’s share price plunged Wednesday morning after the company reported worse third-quarter results than expected, especially in its weight-loss drug division, registering a rare ...

Eli Lilly & Company LLY raised its previously issued 2021 sales and earnings projections, which pushed its shares up more than 10% on Wednesday. The drug giant also issued its financial guidance for ...

Eli Lilly raised its full-year 2021 profit and sales expectations on Wednesday, helped partly by a recent U.S. government contract for its COVID-19 antibody treatment. Adds forecast details, shares ...

INDIANAPOLIS, Nov. 4, 2021 /PRNewswire/ -- Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), today announced that study investigators will present data ...

Eli Lilly & Co. announced Tuesday that it will split its Lilly Bio-Medicines division into two business units: Lilly Neuroscience and Lilly Immunology, effective September 5. Lilly Neuroscience will ...